Exploring the Gut Microbiome's Influence on Obsessive-Compulsive Disorder: Review of Current Literature
DOI:
https://doi.org/10.12775/QS.2025.46.66590Keywords
gut microbiota, gut-brain axis, OCD, obsessive-compulsive disorder, probiotics, fecal microbiota transplantationAbstract
Introduction: Obsessive-compulsive disorder (OCD) is a common and disabling neuropsychiatric condition characterized by obsessions and compulsions, significantly impacting quality of life. Current treatments include pharmacological and psychological therapies. However, the exact etiology remains unclear. Growing research highlights the gut-brain axis and the gut microbiome's influence on mental health.
Aim of the study: This review aims to examine the existing literature on the interplay between the gut microbiome and OCD, exploring its pathophysiological role and therapeutic implications.
Materials and method: An extensive literature search was conducted in the PubMed database up to the year 2025.
Conclusions: This review highlights growing evidence of a significant link between the gut microbiome, the gut-brain axis, and obsessive-compulsive disorder. Changes in gut bacteria can impact brain function and contribute to OCD symptoms. While animal studies have confirmed the existence of the microbiota-gut-brain axis and suggested its role in psychiatric disorder pathogenesis, studies on human remain limited. This gap is especially apparent in out understanding of gut microbiota changes in patients with OCD, marking a critical area for future research. Although research is still emerging, microbiome-targeted interventions – such as probiotics, fecal microbiota transplantation (FMT), and dietary changes – show promise, especially for treatment-resistant OCD. To translate these findings into better patient care, we need increased awareness and more large-scale human studies. These efforts may help identify specific microbial profiles and mechanisms, leading to more effective and personalized treatments for OCD.
References
1. Fawcett EJ, Power H, Fawcett JM. Women Are at Greater Risk of OCD Than Men: A Meta-Analytic Review of OCD Prevalence Worldwide. J Clin Psychiatry. 2020;81(4):19r13085. doi:10.4088/JCP.19r13085
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth ed. Washington, DC, American Psychiatric Association; 2013.
3. Stein DJ. Obsessive-compulsive disorder. Lancet. 2002;360(9330):397-405. doi:10.1016/S0140-6736(02)09620-4
4. Norberg MM, Calamari JE, Cohen RJ, Riemann BC. Quality of life in obsessive-compulsive disorder: an evaluation of impairment and a preliminary analysis of the ameliorating effects of treatment. Depress Anxiety. 2008;25(3):248-259. doi:10.1002/da.20298
5. Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis D., et al. Psychopharmacological treatment of obsessive-compulsive disorder (ocd). Curr Neuropharmacol 2019;17(8):710-736. doi:10.2174/1570159x16666180813155017
6. Deacon BJ, Abramowitz JS. Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings. J Clin Psychol. 2004;60(4):429-441. doi:10.1002/jclp.10255
7. Wu H, Hariz M, Visser-Vandewalle V., et al. Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy?. Mol Psychiatry 2021;26(1):60-65. doi:10.1038/s41380-020-00933-x
8. Steuber ER, McGuire JF. A Meta-analysis of Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023;8(11):1145-1155. doi:10.1016/j.bpsc.2023.06.003
9. Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive–compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014;15(6):410-424. doi:10.1038/NRN3746
10. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-312. doi:10.1016/j.tins.2013.01.005
11. Cryan J, Dinan T. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13(10):701-712. doi:10.1038/nrn3346
12. Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017;20(2):145-155. doi:10.1038/nn.4476
13. De Palma G, Collins SM, Bercik P. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes. 2014;5(3):419-429. doi:10.4161/gmic.29417
14. Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004;558(Pt 1):263-275. doi:10.1113/jphysiol.2004.063388
15. Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461-478. doi:10.1038/s41575-019-0157-3
16. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46-56. doi:10.1038/nrn2297
17. Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):676-692. doi:10.1016/j.pnpbp.2010.05.004
18. Bercik P, Verdu EF, Foster JA, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010;139(6):2102-2112.e1. doi:10.1053/j.gastro.2010.06.063
19. Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264-276. doi:10.1016/j.cell.2015.02.047
20. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050-16055. doi:10.1073/pnas.1102999108
21. Więdłocha M, Marcinowicz P, Janoska-Jaździk M, Szulc A. Gut microbiota, kynurenine pathway and mental disorders - Review. Prog Neuropsychopharmacol Biol Psychiatry. 2021;106:110145. doi:10.1016/j.pnpbp.2020.110145
22. Turna J, Grosman Kaplan K, Anglin R, et al. The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age- and sex-matched controls: a pilot study. Acta Psychiatr Scand. 2020;142(4):337-347. doi:10.1111/acps.13175
23. Domènech L, Willis J, Alemany-Navarro M, et al. Changes in the stool and oropharyngeal microbiome in obsessive-compulsive disorder. Sci Rep. 2022;12(1):1448. doi:10.1038/s41598-022-05480-9
24. Bassett SA, Young W, Barnett MP, Cookson AL, McNabb WC, Roy NC. Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. Nutrients. 2015;7(3):1798-1816. doi:10.3390/nu7031798
25. Quagliariello A, Del Chierico F, Russo A, et al. Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Front Microbiol 2018;9:675.
26. Jung TD, Jung PS, Raveendran L, et al. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole. Behav Pharmacol. 2018;29(2 and 3-Spec Issue):211-224. doi:10.1097/FBP.0000000000000363
27. Scheepers IM, Cryan JF, Bastiaanssen TFS, et al. Natural compulsive-like behaviour in the deer mouse (Peromyscus maniculatus bairdii) is associated with altered gut microbiota composition. Eur J Neurosci. 2020;51(6):1419-1427. doi:10.1111/ejn.14610
28. Shenker BJ, Vitale L, Slots J. Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation. Infect Immun. 1991;59(12):4583-4589. doi:10.1128/iai.59.12.4583-4589.1991
29. Beller A, Kruglov A, Durek P, et al. P104 Anaeroplasma, a potential anti-inflammatory probiotic for the treatment of chronic intestinal inflammation. Ann Rheum Dis 2019;78:A45-A46. doi:10.1136/annrheumdis-2018-EWRR2019.92
30. Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A. Proteobacteria: A Common Factor in Human Diseases. Biomed Res Int. 2017;2017:9351507. doi:10.1155/2017/9351507
31. Loubinoux J, Bronowicki JP, Pereira IA, Mougenel JL, Faou AE. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol. 2002;40(2):107-112. doi:10.1111/j.1574-6941.2002.tb00942.x
32. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010;170(4):1179-1188. doi:10.1016/j.neuroscience.2010.08.005
33. Santocchi E, Guiducci L, Prosperi M, et al. Effects of Probiotic Supplementation on Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial. Front Psychiatry. 2020;11:550593. doi:10.3389/fpsyt.2020.550593
34. Kantak PA, Bobrow DN, Nyby JG. Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG). Behav Pharmacol. 2014;25(1):71-79. doi:10.1097/FBP.0000000000000013
35. Sanikhani NS, Modarressi MH, Jafari P, et al. The Effect of Lactobacillus casei Consumption in Improvement of Obsessive-Compulsive Disorder: an Animal Study. Probiotics Antimicrob Proteins. 2020;12(4):1409-1419. doi:10.1007/s12602-020-09642-x
36. Kobliner V, Mumper E, Baker SM. Reduction in Obsessive Compulsive Disorder and Self-Injurious Behavior With Saccharomyces boulardii in a Child with Autism: A Case Report. Integr Med (Encinitas). 2018;17(6):38-41.
37. Al-Ali D, Ahmed A, Shafiq A, et al. Fecal microbiota transplants: A review of emerging clinical data on applications, efficacy, and risks (2015-2020). Qatar Med J. 2021;2021(1):5. doi:10.5339/qmj.2021.5
38. Kilinçarslan S, Evrensel A. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with inflammatory bowel disease: an experimental study. Actas Esp Psiquiatr. 2020;48(1):1-7.
39. Li N, Chen H, Cheng Y, et al. Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study. Front Cell Infect Microbiol. 2021;11:759435. Published 2021 Oct 19. doi:10.3389/fcimb.2021.759435
40. Kang DW, Adams JB, Gregory AC, et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5(1):10. doi:10.1186/s40168-016-0225-7
41. Kurokawa S, Kishimoto T, Mizuno S, et al. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study. J Affect Disord. 2018;235:506-512. doi:10.1016/j.jad.2018.04.038
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Katarzyna Chmura, Natalia Zygmunt, Małgorzata Skubis-Borowiec, Arnold Borowiec, Anna Chlubek, Jadwiga Kleinrok, Szymon Sychta, Urszula Wąchol, Patrycja Wierzbowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 159
Number of citations: 0
